Status:

COMPLETED

Transcranial Direct and Alternating Stimulation of the Prefrontal Cortex for Cognitive Improvement in Schizophrenia

Lead Sponsor:

The National Brain Mapping Laboratory (NBML)

Collaborating Sponsors:

Ardabil University of Medical Sciences

Leibniz Research Centre for Working Environment and Human Factors

Conditions:

Schizophrenia

Cognitive Dysfunction

Eligibility:

All Genders

18-50 years

Phase:

PHASE1

Brief Summary

The purpose of this study is to investigate different stimulation intensities and frequencies of transcranial direct and alternating current stimulation over the dorsolateral prefrontal cortex for cog...

Detailed Description

In this randomized, double-blind study, 50 patients diagnosed with schizophrenia are randomly assigned into two arms. The first group receives transcranial direct current stimulation (tDCS) at three i...

Eligibility Criteria

Inclusion

  • Diagnosis of schizophrenia based on DSM V,
  • Being 18-50 years old (male and female)
  • If female, negative urine pregnancy test
  • feasibility for tDCS interventions according to safety guidelines
  • stable medication regime especially the classical neuroleptics and all CNS-activating medications, if taken, 4-6 weeks before the experiment
  • fluency in the native language
  • right-handed
  • Required written informed consent signed by patients' guardian

Exclusion

  • pregnancy
  • alcohol or substance dependence
  • history of seizure
  • history of neurological disorder
  • history of head injury
  • Presence of ferromagnetic objects in the body that are contraindicated for brain stimulation of the head (pacemakers or other implanted electrical devices, brain stimulators, some types of dental implants, aneurysm clips, metallic prostheses, permanent eyeliner, implanted delivery pump, or shrapnel fragments) or fear of enclosed spaces).

Key Trial Info

Start Date :

April 1 2021

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

July 31 2022

Estimated Enrollment :

50 Patients enrolled

Trial Details

Trial ID

NCT05342727

Start Date

April 1 2021

End Date

July 31 2022

Last Update

August 8 2022

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Ardabil University of Medical Sciences

Ardabil, Iran